Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID<sup>®</sup>) with Concomitant Medications in Real-World Clinical Settings
Background: This research article delves into the battle against the COVID-19 pandemic, focusing on the efficacy and, particularly, the safety of the combination of nirmatrelvir with ritonavir, which is found in the pharmaceutical product Paxlovid<sup>®</sup>. This study aims to analyze the potentia...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-11-01
|
| シリーズ: | Pathogens |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2076-0817/13/12/1055 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|